DuPont is a science and technology company that focuses on delivering innovative solutions across various industries through its advanced materials, specialty products, and biotechnology. The company operates in sectors such as electronics, water, food, pharmaceuticals, and agriculture, with a commitment to sustainability and efficiency. DuPont leverages its extensive research and development capabilities to create products that enhance the performance of its clients, improve safety, and reduce environmental impact, all while driving growth and addressing global challenges. Read More
The latest earnings season, spanning late July and early August 2025, has painted a vivid picture of a bifurcated market, where the titans of technology continue to defy gravity, largely propelled by their aggressive and strategic investments in Artificial Intelligence (AI). While companies like Amazon, Apple, Meta, and Microsoft reported
Early August 2025 has seen a dynamic U.S. stock market, characterized by a blend of cautious optimism and significant individual company surges. While broader market indices like the S&P 500 and Nasdaq experienced some volatility at the close of July, a rebound in early August, particularly within the
Stocks slipped Tuesday as fresh economic data reignited stagflation fears on Wall Street, overshadowing a blowout quarter from Palantir Technologies Inc.
DuPont stock rose after beating Q2 expectations on earnings and revenue, raising full-year outlook due to strong demand in electronics, healthcare, and water markets.
DuPont Q2 2025 earnings: Revenue missed at $3.26B, but EPS beat at $1.12. Shares rose 5.4% as guidance was raised on strong electronics and water demand.
The Chemours Company (NYSE: CC), DuPont de Nemours, Inc. (NYSE: DD), and Corteva, Inc. (NYSE: CTVA) (the “Companies”) today announced a settlement to comprehensively resolve all pending environmental and other claims by the State of New Jersey against the Companies in various litigation matters and other state directives. The Settlement will resolve all legacy contamination claims related to the companies’ current and former operating sites (Chambers Works, Parlin, Pompton Lakes and Repauno) and claims of statewide PFAS contamination unrelated to those sites, including from the use of aqueous film forming foam.
NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of DuPont de Nemours, Inc. (“DuPont” or the “Company”) (NYSE: DD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of DuPont de Nemours, Inc. (“DuPont” or the “Company”) (NYSE: DD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of DuPont de Nemours, Inc. (“DuPont” or the “Company”) (NYSE: DD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of DuPont de Nemours, Inc. (“DuPont” or the “Company”) (NYSE: DD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
